Wells Fargo & Company Singular Genomics Systems, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.4 - $0.61 $2 - $4	7 Added 1.86%	384 $0
Q4 2023 Feb 09, 2024	BUY	$0.33 - $0.58 $6 - $11	20 Added 5.6%	377 $0
Q3 2023 Nov 13, 2023	BUY	$0.37 - $0.99 $15 - $40	41 Added 12.97%	357 $0
Q2 2023 Aug 15, 2023	SELL	$0.78 - $1.28 $7,512 - $12,328	-9,632 Reduced 96.82%	316 $0
Q1 2023 May 12, 2023	SELL	$1.1 - $2.95 $31,876 - $85,488	-28,979 Reduced 74.44%	9,948 $12,000
Q4 2022 Feb 13, 2023	SELL	$1.82 - $2.71 $1,117 - $1,663	-614 Reduced 1.55%	38,927 $78,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.73 $1,930 - $3,651	-772 Reduced 1.92%	39,541 $99,000
Q2 2022 Aug 12, 2022	BUY	$2.86 - $6.44 $105,842 - $238,331	37,008 Added 1119.76%	40,313 $154,000
Q1 2022 May 16, 2022	BUY	$5.94 - $12.09 $17,796 - $36,221	2,996 Added 969.58%	3,305 $21,000
Q4 2021 Feb 14, 2022	BUY	$10.45 - $16.9 $2,643 - $4,275	253 Added 451.79%	309 $3,000
Q3 2021 Nov 15, 2021	BUY	$10.9 - $27.63 $610 - $1,547	56 New	56 $1,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $419M
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.